Rank #1788AGIO

Agios Pharmaceuticals, Inc.

$28.58

3.70% (Daily)

Market Cap

$1.67B

Revenue

$54.03M

Rank by MCap

#1788

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Brian M. Goff M.B.A.

Headquarters

Cambridge, MA

Employees

539

About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in p...